Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

Aim. To evaluate diagnostic and prognostic value of C-reactive protein (CRP), procalcitonin (PCT) and presepsin (PSP) in patients with malignant lymphoproliferative disorders after a high-dose chemotherapy and auto-HSCT. Methods. 28 patients were included in the study (20 women and 8 men; 12 of t...

Full description

Saved in:

Bibliographic Details
Main Authors:	VO Sarzhevskii, YuN Dubinina, VYa Mel’nichenko
Format:	Article
Language:	Russian
Published:	Practical Medicine Publishing House 2017-01-01
Series:	Клиническая онкогематология
Subjects:	high-dose chemotherapy autologous hematopoietic stem cells transplantation infection presepsin procalcitonin C-reactive protein
Online Access:	http://bloodjournal.ru/wp-content/uploads/2017/01/15.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders
by: VO Sarzhevskii, et al.
Published: (2016-10-01)

Role of Biochemical Inflammatory Markers in Patients with Chemotherapy-Induced Neutropenia
by: YuN Dubinina, et al.
Published: (2019-09-01)

Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery
by: NE Mochkin, et al.
Published: (2018-07-01)

Comparative Efficacy Analysis of Mobilization and Collection of Autologous Hematopoietic Stem Cells in Patients with Lymphoproliferative Disorders and Multiple Sclerosis
by: OV Fedyk, et al.
Published: (2018-12-01)

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH SEVERE RESISTANT MULTIPLE SCLEROSIS
by: K. I. Kirgizov, et al.
Published: (2013-02-01)

CLINICAL EFFECTIVENESS OF HIGH-DOSE IMMUNOSUPPRESSIVE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS PATIENTS
by: D. A. Fedorenko, et al.
Published: (2014-12-01)

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA
by: V. G. Potapenko, et al.
Published: (2017-01-01)

PRESEPSIN AS THE EARLY MARKER OF PURULENT SEPTIC COMPLICATIONS IN PATIENTS WITH SEVERE ACUTE PANCREATITIS
by: N. N. Salina, et al.
Published: (2018-04-01)

The optimal time for autologous hematopoietic progenitor cell transplantation during treatment of Hodgkin's lymphoma. Foreign recommendations and russian experience
by: N. V. Zhukov, et al.
Published: (2014-09-01)

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2<sup>nd</sup> line treatment before autologous hematopoietic stem cell transplantation (preliminary results)
by: A. A. Mamedova, et al.
Published: (2022-07-01)

Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients
by: EL Nazarova, et al.
Published: (2018-01-01)

Autologous Hematopoietic Cell Transplant as an Effective Treatment Modality for Systemic Sclerosis and Multiple Myeloma
by: Memon H, et al.
Published: (2025-01-01)

IMMUNE STATE IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AT LATE TERMS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: N. V. Minaeva, et al.
Published: (2014-07-01)

THE EFFICACY OF HIGH-DOSE CONSOLIDATION AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST REMISSION OF ACUTE MYELOID LEUKEMIA
by: I. A. Samorodova, et al.
Published: (2018-05-01)

Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
by: OV Pirogova, et al.
Published: (2018-04-01)

The effectiveness of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in the treatment
by: T. V. Yukhta, et al.
Published: (2019-12-01)

Quality of life before autologous stem cells transplantation as prognostic factor in patients with malignant lymphomas
by: Yu. L. Shevchenko, et al.
Published: (2014-07-01)

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients
by: N. V. Zhukov, et al.
Published: (2014-07-01)

Autologous hematopoietic stem cell transplantation as a method of immune prevention of type 1 diabetes mellitus: possibilities and prospects
by: M. E. Chernaya, et al.
Published: (2024-07-01)

The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs
by: Xixi Wan, et al.
Published: (2025-02-01)

Autologous hematopoietic stem cell transplantation in patients with POEMS-syndrome: a literature review and own data
by: A. V. Popova, et al.
Published: (2025-03-01)

Epidemiology of bacteremia after autologous hematopoietic stem cell transplantation in the absence of antibiotic prophylaxis
by: Rima Moghnieh, et al.
Published: (2018-02-01)

Certain Aspects of Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2017-01-01)

Gemcitabine–oxaliplatin as a bridge therapy toward autologous hematopoietic stem cell transplantation in infant-type brain tumors
by: Barbara Castelli, et al.
Published: (2025-05-01)

Dermatologic toxicity of high doses of tiothepa in children. Case report
by: Teimur Z. Aliev, et al.
Published: (2023-05-01)

The optimal time for hematopoietic stem cell translantation for Hodgkin's lymphoma. International guidelines and real practic in Russia and former USSSR countries (Part II)
by: N. V. Zhukov, et al.
Published: (2015-01-01)

Role of biomarkers in the diagnosis of bacterial infections in rheumatic diseases
by: B. S. Belov, et al.
Published: (2019-07-01)

Procalcitonin, Presepsin, Endocan, and Interleukin-6 in the Early Diagnosis of Neonatal Sepsis—A Prospective Study
by: Maura-Adelina Hincu, et al.
Published: (2025-05-01)

Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2019-05-01)

Recent advancements in hematopoietic stem cell transplantation in Taiwan
by: Chi-Cheng Li, et al.
Published: (2024-01-01)

Biomarkers of progressive multiple sclerosis decrease following autologous hematopoietic stem cell transplantation
by: Ida Erngren, et al.
Published: (2025-07-01)

Netupitant / palonosetron with dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous hematopoietic stem cell transplantation: a single-center experience
by: N. E Mochkin, et al.
Published: (2025-03-01)

Analysis of factors influencing platelet transfusion in children with high-risk stage Ⅳ neuroblastoma undergoing autologous hematopoietic stem cell transplantation
by: FU Xiaoyan, et al.
Published: (2025-07-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN ELDERLY ACUTE MYELOID LEUKEMIA
by: Gert J. Ossenkoppele, et al.
Published: (2013-02-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Use of high-dosage chemotherapy with autologous hematopoietic stem cell transplantation as a first-line therapy for the patients with poor-prognosis testicular tumors
by: Marjanović Slobodan, et al.
Published: (2005-01-01)

The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia
by: Zeynep Canan Özdemir, et al.
Published: (2019-06-01)

Autologous hematopoietic stem cell transplantation in remission consolidation of acute myeloid leukemia with initially unfavorable prognostic factors
by: G. D. Petrova, et al.
Published: (2016-03-01)

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients
by: S. V. Voloshin, et al.
Published: (2022-04-01)

Application of mass cytometry to characterize hematopoietic stem cells in apheresis products of patients with hematological malignancies
by: Carlos Agustin Villegas-Valverde, et al.
Published: (2024-12-01)